Drug Firm Roche India
- All
- News
-
High Court Asks Centre To Meet Pharma Firm For Immediate Supply Of Tocilizumab Drug
In view of the "acute shortage" of Tocilizumab drug, which is prescribed to a large number of Covid patients, the high court has directed the Centre and Department of Pharmaceuticals to hold a meeting with Roche, which sells the drug.
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
Big Pharma pushes for US action against India over patent worries: report
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.
-
Roche cancer drug suffers patent setback in India
India has partly revoked patents granted to a Roche Holding AG breast cancer medicine, the Swiss firm said on Sunday, in the latest regulatory setback for western drug makers trying to crack the fast-growing market.
-
Roche to launch cheaper cancer drugs in India
The Swiss firm has tied up with Emcure Pharmaceuticals Ltd to launch local brands of its Herceptin and Mabthera cancer drugs.
-
High Court Asks Centre To Meet Pharma Firm For Immediate Supply Of Tocilizumab Drug
In view of the "acute shortage" of Tocilizumab drug, which is prescribed to a large number of Covid patients, the high court has directed the Centre and Department of Pharmaceuticals to hold a meeting with Roche, which sells the drug.
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
Big Pharma pushes for US action against India over patent worries: report
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.
-
Roche cancer drug suffers patent setback in India
India has partly revoked patents granted to a Roche Holding AG breast cancer medicine, the Swiss firm said on Sunday, in the latest regulatory setback for western drug makers trying to crack the fast-growing market.
-
Roche to launch cheaper cancer drugs in India
The Swiss firm has tied up with Emcure Pharmaceuticals Ltd to launch local brands of its Herceptin and Mabthera cancer drugs.
